Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|October 28, 2004
A point mutation in a silencer module reduces the promoter activity for the human mercaptopyruvate sulfurtransferaseNoriyuki Nagahara, V G Sreeja, Qing Li, et al.
The Angle Orthodontist|February 2, 2006
Expression of Notch1 and Math1 in mandibular condyle cartilage in neonatal miceTakako Shimizu, Hidetsugu Tsujigiwa, Hitoshi Nagatsuka, et al.
Archives of Biochemistry and Biophysics|January 13, 2006
Expression of enzymatically active human granzyme 3 in Escherichia coli for analysis of its substrate specificityYukiyo Hirata, Hirofumi Inagaki, Takako Shimizu, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 7, 2014
[Acute encephalitis with refractory partial status epilepticus treated with early immunotherapies including plasma exchange: a case report]Daisuke Yamamoto, Tsuyoshi Uchiyama, Tomoyasu Bunai, et al.
Journal of Clinical Pharmacology|August 24, 2017
Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal ImpairmentManabu Kato, Naoyuki Tajima, Takako Shimizu, et al.
Clinical and Translational Science|October 13, 2025
Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A/P-gp ModulatorsAkiko Watanabe, Noriko Okudaira, Masaya Tachibana, et al.
Rinsho Shinkeigaku = Clinical Neurology|February 23, 2012
[A case of cerebral amyloid angiopathy with reversible white matter lesions and multiple cerebral microbleeds]Yasushi Hosoi, Tsuyoshi Uchiyama, Mari Yoshida, et al.
Rinsho Shinkeigaku = Clinical Neurology|November 26, 2009
[A case report of primary central nervous system lymphoma preceded by cerebral and cerebellar lesion diminishing spontaneously: consideration of two brain biopsy at the onset and after two years]Makiko Suzuki, Tsuyoshi Uchiyama, Hitoshi Takahashi, et al.
Clinical and Translational Science|September 14, 2023
Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjectsMasaya Tachibana, Shunji Matsuki, Yutaro Maekawa, et al.
Clinical Pharmacology in Drug Development|February 24, 2024
Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug ExposureShintaro Nakayama, Viera Lukacova, Shuichi Tanabe, et al.
Pageof 8